These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3307620)

  • 1. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults.
    Douglas RM; Miles HB; Moore BW; Ryan P; Pinnock CB
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1263-5. PubMed ID: 3307620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of zinc gluconate in treatment of acute upper respiratory tract infections.
    Smith DS; Helzner EC; Nuttall CE; Collins M; Rofman BA; Ginsberg D; Goswick CB; Magner A
    Antimicrob Agents Chemother; 1989 May; 33(5):646-8. PubMed ID: 2665639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges.
    Al-Nakib W; Higgins PG; Barrow I; Batstone G; Tyrrell DA
    J Antimicrob Chemother; 1987 Dec; 20(6):893-901. PubMed ID: 3440773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of zinc lozenges in treatment of the common cold.
    Garland ML; Hagmeyer KO
    Ann Pharmacother; 1998 Jan; 32(1):63-9. PubMed ID: 9475824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial.
    Hemilä H; Haukka J; Alho M; Vahtera J; Kivimäki M
    BMJ Open; 2020 Jan; 10(1):e031662. PubMed ID: 31980506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis.
    Hemilä H; Petrus EJ; Fitzgerald JT; Prasad A
    Br J Clin Pharmacol; 2016 Nov; 82(5):1393-1398. PubMed ID: 27378206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial.
    Eby GA; Halcomb WW
    Altern Ther Health Med; 2006; 12(1):34-8. PubMed ID: 16454145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial.
    Reding P; Duchateau J; Bataille C
    Lancet; 1984 Sep; 2(8401):493-5. PubMed ID: 6147551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial.
    Prasad AS; Fitzgerald JT; Bao B; Beck FW; Chandrasekar PH
    Ann Intern Med; 2000 Aug; 133(4):245-52. PubMed ID: 10929163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.
    Farr BM; Conner EM; Betts RF; Oleske J; Minnefor A; Gwaltney JM
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1183-7. PubMed ID: 2820298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc lozenges as cure for the common cold--a review and hypothesis.
    Eby GA
    Med Hypotheses; 2010 Mar; 74(3):482-92. PubMed ID: 19906491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc ion availability--the determinant of efficacy in zinc lozenge treatment of common colds.
    Eby GA
    J Antimicrob Chemother; 1997 Oct; 40(4):483-93. PubMed ID: 9372416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.
    Mossad SB; Macknin ML; Medendorp SV; Mason P
    Ann Intern Med; 1996 Jul; 125(2):81-8. PubMed ID: 8678384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.
    Eby GA; Davis DR; Halcomb WW
    Antimicrob Agents Chemother; 1984 Jan; 25(1):20-4. PubMed ID: 6367635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection.
    Ebel DL; Shih WJ; Rhymer AR
    Curr Med Res Opin; 1985; 9(10):666-75. PubMed ID: 3907988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults.
    Belongia EA; Berg R; Liu K
    Am J Med; 2001 Aug; 111(2):103-8. PubMed ID: 11498062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a combination herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix for the prophylactic treatment of patients with respiratory tract diseases: a randomised, prospective, double-blind, placebo-controlled phase III trial.
    Fintelmann V; Albrecht U; Schmitz G; Schnitker J
    Curr Med Res Opin; 2012 Nov; 28(11):1799-807. PubMed ID: 23083066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection.
    McNally D; Shephard A; Field E
    J Pharm Pharm Sci; 2012; 15(2):281-94. PubMed ID: 22579007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold.
    Farr BM; Gwaltney JM
    J Chronic Dis; 1987; 40(9):875-9. PubMed ID: 3298301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds.
    Turner RB; Cetnarowski WE
    Clin Infect Dis; 2000 Nov; 31(5):1202-8. PubMed ID: 11073753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.